RiverVest Venture Partners® is a venture capital firm focused on identifying and shaping early-stage life science companies to create significant shareholder value. With hands-on, high-level expertise and financial resources, RiverVest supports entrepreneurs by helping them achieve near-term objectives that position their companies for exit.
- Sep 01, 2010
Accumetrics Increases Capital Raise, Completes Final Close in $24 Million Capital Financing - Aug 30, 2010
Otonomy Closes $38.5 Million Series B Financing - Jul 13, 2010
Accumetrics, Inc., Daiichi Sankyo, Inc. and Eli Lilly and Company Launch Strategic U.S. Collaboration - Jun 25, 2010
GILEAD SCIENCES TO ACQUIRE CGI PHARMACEUTICALS FOR UP TO $120 MILLION
|




